4//SEC Filing
Nolan Sean P. 4
Accession 0001209191-23-046150
CIK 0001806310other
Filed
Aug 15, 8:00 PM ET
Accepted
Aug 16, 8:52 PM ET
Size
5.6 KB
Accession
0001209191-23-046150
Insider Transaction Report
Form 4
Nolan Sean P.
DirectorChief Executive Officer
Transactions
- Purchase
Common Stock
2023-08-16$0.90/sh+444,444$400,000→ 1,535,545 total(indirect: See Footnote)
Holdings
- 1,170
Common Stock
Footnotes (1)
- [F1]The securities are held by Nolan Capital, LLC (the "LLC"). The Reporting Person is the President of the LLC and has shared voting and investment power with respect to the shares held by the LLC.
Documents
Issuer
Taysha Gene Therapies, Inc.
CIK 0001806310
Entity typeother
Related Parties
1- filerCIK 0001569926
Filing Metadata
- Form type
- 4
- Filed
- Aug 15, 8:00 PM ET
- Accepted
- Aug 16, 8:52 PM ET
- Size
- 5.6 KB